HIV: Trispecific antibodies block infection

Nature Reviews Drug Discovery 16, 754 (2017). doi:10.1038/nrd.2017.208 Author: Sarah Crunkhorn The use of broadly neutralizing antibodies (bnAbs) isolated from HIV-infected individuals in the development of an effective AIDS vaccine has been limited by potency and breadth of protection. Now, Xu et al. report the generation of multi-specific antibodies derived from bnAbs with specificities for
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: Research Highlight Source Type: research